Intangible Assets

NHP appears to operate in a regulated healthcare services niche where licenses, compliance processes, and clinical relationships can create some local differentiation, but these assets are generally not exclusive versus larger peers.

Compared with scaled healthcare operators, any brand or reputation benefit is likely regional and service-specific rather than a durable, system-wide pricing advantage.

The absence of strong margin or ROIC evidence in the provided metrics suggests intangible assets are not translating into materially superior economics versus peers.

Because similar care models and regulatory frameworks are available to other operators, intangible assets support retention more than they support sustained premium pricing.

Switching Costs

Patients and referral sources in healthcare can face some friction when changing providers, but that friction is usually driven by convenience and care continuity rather than hard contractual lock-in.

Compared with peers in more integrated or specialized care settings, NHP’s switching costs appear limited because alternative providers can often substitute with manageable disruption.

The very low TTM ROIC and ROCE indicate that any retention benefit is not strong enough to produce durable excess returns versus peers.

Switching costs likely help preserve volume in specific service lines, but they do not appear high enough to materially constrain competitive entry or pricing pressure.

Network Effects

NHP does not appear to benefit from a meaningful network effect because patient demand for healthcare services is not inherently self-reinforcing in the way platform businesses are.

Compared with peers that may have broader referral networks or integrated delivery systems, there is no evidence here of ecosystem-driven compounding that would raise moat durability.

The provided financial metrics do not show the kind of margin or capital efficiency uplift that would typically accompany strong network effects.

Any referral flow advantages are likely local and operational rather than a true network moat that compounds over time.

Cost Advantage

NHP’s TTM ROIC of about 0.8% and ROCE of about 0.9% suggest it is not converting scale or operations into a cost position meaningfully better than peers.

A negative cash conversion cycle can support working-capital efficiency, but by itself it does not establish a durable unit-cost advantage versus other healthcare operators.

Without evidence of superior margins, procurement leverage, or structurally lower labor or facility costs, cost advantage appears limited and replicable.

Relative to larger peers, NHP likely lacks the purchasing power and operating density needed to sustain a persistent cost edge.

Efficient Scale

Healthcare delivery can exhibit some local efficient-scale characteristics where a limited number of providers serve a catchment area, but this is usually geography-specific rather than industry-wide.

Compared with dominant regional systems, NHP may benefit from some localized density, yet the market structure does not appear to prevent meaningful peer entry or expansion.

The weak capital returns imply that any scale benefits are not currently strong enough to create a durable barrier to competition.

Efficient scale is therefore present only in a modest, local sense and does not look sufficient to support strong long-term moat durability versus peers.

Overall Score

NHP’s moat appears weak versus peers because the business shows only modest local switching frictions and limited regulatory or relationship-based differentiation, while the provided profitability metrics do not indicate durable pricing power, retention advantage, or cost leadership.